Testing - Import export

The Green Spring® SARSCoV2 antigen rapid test is used for the rapid, qualitative detection of the nucleocapsid protein antigen of SARSCoV2 in human saliva, nasal, nasopharyngeal or throat swab samples. The results are used to detect SARSCoV2 antigens. The antigen is generally detectable in specimens from the upper respiratory tract during the acute phase of infections. Positive results do not rule out bacterial infection or coinfection with other viruses. The identified pathogen may not be the sole cause of the disease.

The Clungene COVID19 antigen rapid test is based on a lateral flow immunoassay method and is used for the qualitative detection of an acute COVID19 infection. For this purpose, the medical specialist or a trained user takes a nasal, nasopharyngeal or oropharyngeal swab from the patient and receives the results after about 15 minutes with the direct swab test method.